Patent assignee · US · COMPANY

SINGULAR IMMUNE, INC.

1Patents
1Active
1Granted
52Portfolio score

Filing activity: Mar 17, 2023 → Mar 17, 2023

Most-cited patents

PatentTitleAreaCited byStatus
US12005082B2 Composition and method of use recombinant fusion protein to generate CAR-immune cells Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.